The global gene therapy market is booming, projected to reach $50.7 billion by 2033 with a 28% CAGR. Driven by advancements in viral vectors and increasing prevalence of genetic disorders, this report analyzes market trends, key players (Roche, Astellas, Gilead), and regional growth across North America, Europe, and Asia-Pacific.
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.